company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,110522454.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1054674.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,111577128.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,104516.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,85200.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126835.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,262138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,,totalassets,Total Assets,=,debit,usd,111943782.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,567893.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,777524.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21881.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1417401.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,29748.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,415442.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,445190.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1862591.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,124109632.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-14028441.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,110081191.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,110081191.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,110081191.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,,2015-03-31,2015-05-06 16:06:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,111943782.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,106011672.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,810174.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,106821846.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,118992.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,85200.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126835.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,262138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,,totalassets,Total Assets,=,debit,usd,107202976.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,812321.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1229351.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21881.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2113656.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,27527.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,415442.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,442969.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2556625.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,125753190.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-21106839.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,104646351.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,104646351.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,104646351.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,,2015-06-30,2015-08-05 17:06:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107202976.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,89159535.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9999478.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1085501.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,100244514.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,255681.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,85200.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126835.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,262138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,,totalassets,Total Assets,=,debit,usd,100762333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,692677.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1559540.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21881.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,50103.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2324201.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,22807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,415442.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,438249.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2762450.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,127263242.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-29259683.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3676.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,97999883.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,97999883.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,97999883.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,,2015-09-30,2015-11-04 17:13:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,100762333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53999629.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,30377177.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,112569.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1992445.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,86481820.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,578539.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,64800.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126835.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,191635.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,,totalassets,Total Assets,=,debit,usd,87251994.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1541295.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1478547.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,24174.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3044016.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,22575.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15442.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,38017.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3082033.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,130895307.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-46744951.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19605.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,84169961.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,84169961.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,84169961.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,,2016-03-31,2016-05-04 17:18:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,87251994.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38941239.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35912780.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,274302.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2259865.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77399781.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,637050.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,64800.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126835.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,191635.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,,totalassets,Total Assets,=,debit,usd,78228466.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1544760.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1761777.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,90790.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3397327.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,15656.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,15656.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3412983.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,132884077.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-58108084.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,39490.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,74815483.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,74815483.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,74815483.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,,2016-06-30,2016-08-03 16:54:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,78228466.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27829591.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,39504263.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21787.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,230778.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1554270.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,69140689.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,619371.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,64800.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,191395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,,totalassets,Total Assets,=,debit,usd,69951455.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1256889.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2549443.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,106750.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3913082.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10561.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10561.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3923643.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,134758718.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-68745578.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14672.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,66027812.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,66027812.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,66027812.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,,2016-09-30,2016-11-02 16:43:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,69951455.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21071684.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,31743086.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19062.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,414322.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1585715.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,54833869.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,479266.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,64800.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,191395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,,totalassets,Total Assets,=,debit,usd,55504530.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,818794.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2311405.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,88216.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3218415.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,59111.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,59111.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3277526.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,137153365.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-84914008.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12353.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,52227004.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,52227004.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,52227004.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,,2017-03-31,2017-05-03 16:48:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,55504530.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39126801.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,7996199.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,34735.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,688185.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1209192.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,49055112.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,448102.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,,totalassets,Total Assets,=,debit,usd,49629809.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1806359.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3130394.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,96667.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5033420.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,91878.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,91878.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5125298.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,138228758.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-93718631.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5616.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44504511.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44504511.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44504511.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,,2017-06-30,2017-08-02 16:11:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,49629809.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20152129.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,18776390.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,35134.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,533996.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1056179.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,40553828.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,400991.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,253190.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,253190.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,,totalassets,Total Assets,=,debit,usd,41208009.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,919030.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3897184.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,156392.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4972606.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,53919.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,53919.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5026525.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,139233539.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-103050744.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1311.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,36181484.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,36181484.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,36181484.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,,2017-09-30,2017-11-06 08:43:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,41208009.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21948395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1999399.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12631.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,418196.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1261232.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,25639853.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,266647.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,,totalassets,Total Assets,=,debit,usd,26033095.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2241402.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1820292.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,58821.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4120515.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24509.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24509.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4145024.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,141150263.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-119262285.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,93.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,21888071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,21888071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,21888071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,,2018-03-31,2018-05-02 16:16:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,26033095.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,15756971.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17329.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,275693.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,856118.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16906111.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,180044.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,,totalassets,Total Assets,=,debit,usd,17212750.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1145333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2588596.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,58821.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3792750.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9804.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9804.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3802554.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,141724353.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-128314157.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,13410196.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,13410196.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,13410196.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,,2018-06-30,2018-08-01 16:31:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,17212750.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12961126.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20993.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,223519.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,478746.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,13684384.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,127090.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,126595.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,,totalassets,Total Assets,=,debit,usd,13938069.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1279258.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1554679.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,53919.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2887856.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2887856.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,142002743.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-130952530.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11050213.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11050213.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11050213.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,,2018-09-30,2018-11-05 16:11:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,13938069.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7297468.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9069.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,164597.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,675277.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,8146411.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,38008.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,,totalassets,Total Assets,=,debit,usd,8184419.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,186349.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,724769.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,911118.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,911118.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,142465006.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-135191705.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,7273301.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,7273301.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7273301.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,,2019-03-31,2019-05-01 16:11:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8184419.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6514215.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,28278.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,130920.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,435972.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7109385.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,27954.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,,totalassets,Total Assets,=,debit,usd,7137339.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,805516.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,230752.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1036268.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1036268.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,142677553.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-136576482.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6101071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6101071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6101071.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,,2019-06-30,2019-07-17 17:02:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7137339.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3999676.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1239708.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,5239384.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,28144.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8865909.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,324509.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9190418.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,,totalassets,Total Assets,=,debit,usd,14457946.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,749157.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1647512.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,245603.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1580394.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,498247.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4720913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4720913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,19930912.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-10193879.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9737033.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9737033.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,9737033.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,,2019-09-30,2019-11-12 16:31:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,14457946.0
